Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site
Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to Evaluate of the analgesic effect of ropivacaine in topical use at
the thin skin graft donor site.
For Patient needing a thin skin graft < 320 cm2, randomization will be done in 2 groups, one
receiving the standard treatment (20 mL of physiologic serum) during the surgical
intervention in topical use to recover an alginate dressing (Algosteril)and the other receive
20 mL of Naropein during the surgical intervention on alginate dressing.
The hypothesis of the study is the administration of ropivacaine will decrease the
post-operative pain compared to physiologic serum